Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis

Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis

<p><strong>Background and aims:</strong> Weight loss is recommended for patients with non-alcoholic steatohepatitis (NASH) but the impact of weight change on disease activity remains unclear. We examined the association between weight change (gain/loss) and changes in biochemical a...

Full description

Bibliographic Details
Main Authors:	Koutoukidis, D, Jebb, S, Tomlinson, J, Cobbold, J, Aveyard, P
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Similar Items

Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life
by: Heath, L, et al.
Published: (2022)

A low-energy total diet replacement programme demonstrates a favourable safety profile and improves liver disease severity in non-alcoholic steatohepatitis
by: Koutoukidis, D, et al.
Published: (2023)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2011)

Liraglutide for patients with non-alcoholic steatohepatitis.
by: Dale, A, et al.
Published: (2016)

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
by: Newsome, P, et al.
Published: (2012)

Association of weight loss interventions with changes in biomarkers of non-alcoholic fatty liver disease: A systematic review and meta-analysis
by: Koutoukidis, DA, et al.
Published: (2019)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis
by: Koutoukidis, DA, et al.
Published: (2021)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2015)

Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
by: Dennis, A, et al.
Published: (2021)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
by: Armstrong, M, et al.
Published: (2014)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2014)

Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
by: Kamarajah, Sivesh Kathir, et al.
Published: (2019)

Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: an international physician needs assessment
by: Lazure, P, et al.
Published: (2022)

Association between the month of starting a weight management program and weight change in people at high risk of type 2 diabetes: a prospective cohort study
by: Koutoukidis, D, et al.
Published: (2023)

Hepatocellular carcinoma in a non-B non-C non-alcoholic steatohepatitis (NBNC-NASH HCC)
by: M. F., Fairudz, et al.
Published: (2010)

Predicting clinical endpoints and visual changes with quality-weighted tissue-based renal histological features
by: Tam, KH, et al.
Published: (2024)

A classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy
by: Yu, Yang, et al.
Published: (2018)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
by: Arora, A, et al.
Published: (2021)

The effect of moderate weight loss on a non-invasive biomarker of liver fibrosis: a randomised controlled trial
by: Koutoukidis, DA, et al.
Published: (2020)

The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Koutoukidis, DA, et al.
Published: (2020)

Weight change among people randomized to minimal intervention control groups in weight loss trials
by: Johns, D, et al.
Published: (2016)

A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
by: Dennis, A, et al.
Published: (2020)

Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy
by: Yan, Jie, et al.
Published: (2019)

Imaging endpoints for non-alcoholic steatohepatitis (NASH) therapeutic trials: A growing role for multiparametric MRI?
by: Banerjee, R, et al.
Published: (2018)

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?
by: Tariq, Z, et al.
Published: (2014)

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?
by: Tariq, Z, et al.
Published: (2014)

The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis
by: Koutoukidis, DA, et al.
Published: (2022)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
by: Armstrong, M, et al.
Published: (2013)

Non-alcoholic fatty liver disease and diabetes.
by: Hazlehurst, J, et al.
Published: (2016)

Programme characteristics associated with weight change following behavioural weight loss programmes: a systematic review and meta-analysis
by: Hartmann-Boyce, J, et al.
Published: (2021)

Weight change over eight years in relation to alcohol consumption in a cohort of continuing smokers and quitters.
by: Lycett, D, et al.
Published: (2011)

Photoplethysmography Features Correlated with Blood Pressure Changes
by: Elgendi, Mohamed, et al.
Published: (2024)

Non-alcoholic fatty liver disease
by: Pavlides, M, et al.
Published: (2019)

Temporal changes in metabolic fitness with modest weight loss.
by: Krebs, J, et al.
Published: (2001)

Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
by: Armstrong, M, et al.
Published: (2013)

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
by: Marjot, T, et al.
Published: (2019)

Weight Watchers on prescription: an observational study of weight change among adults referred to Weight Watchers by the NHS.
by: Ahern, A, et al.
Published: (2011)

Features from the photoplethysmogram and the electrocardiogram for estimating changes in blood pressure
by: Finnegan, E, et al.
Published: (2023)

Are markers of proliferation valuable in the histological assessment of pituitary tumours?
by: Turner, H, et al.
Published: (1999)